The pathophysiological and immunological background of the monkeypox virus infection: An update
- PMID: 36217803
- DOI: 10.1002/jmv.28206
The pathophysiological and immunological background of the monkeypox virus infection: An update
Expression of concern in
-
The pathophysiological and immunological background of the monkeypox virus infection: An update.J Med Virol. 2024 Mar;96(3):e29508. doi: 10.1002/jmv.29508. J Med Virol. 2024. PMID: 38450819 No abstract available.
Abstract
In addition to the COVID-19 waves, the globe is facing global monkeypox (MPX) outbreak. MPX is an uncommon zoonotic infection characterized by symptoms similar to smallpox. It is caused by the monkeypox virus (MPXV), a double-stranded DNA virus that belongs to the genus Orthopoxvirus (OPXV). MPXV, which causes human disease, has been confined to Africa for many years, with only a few isolated cases in other areas. Outside of Africa, the continuing MPXV outbreak in multiple countries in 2022 is the greatest in recorded history. The current outbreak, with over 10 000 confirmed cases in over 50 countries between May and July 2022, demonstrates that MPXV may travel rapidly among humans and pose a danger to human health worldwide. The rapid spread of such outbreaks in recent times has elevated MPX to the status of a rising zoonotic disease with significant epidemic potential. While the MPXV is not as deadly or contagious as the variola virus that causes smallpox, it poses a threat because it could evolve into a more potent human pathogen. This review assesses the potential threat to the human population and provides a brief overview of what is currently known about this reemerging virus. By analyzing the biological effects of MPXV on human health, its shifting epidemiological footprint, and currently available therapeutic options, this review has presented the most recent insights into the biology of the virus. This study also clarifies the key potential causes that could be to blame for the present MPX outbreak and draw attention to major research questions and promising new avenues for combating the current MPX epidemic.
Keywords: immunity; monkeypox; pathogen; smallpox; zoonotic.
© 2022 Wiley Periodicals LLC.
Similar articles
-
Correlation between microneutralization test and a multiplexed immunoassay for evaluation of monkeypox and vaccinia virus antibodies before and after smallpox vaccination.Front Immunol. 2025 Jun 23;16:1585284. doi: 10.3389/fimmu.2025.1585284. eCollection 2025. Front Immunol. 2025. PMID: 40625755 Free PMC article.
-
Exploring monkeypox virus antibody levels: insights from human immunological research.Virol J. 2025 May 31;22(1):175. doi: 10.1186/s12985-025-02748-0. Virol J. 2025. PMID: 40450351 Free PMC article. Review.
-
Monkeypox: An outbreak of a rare viral disease.J Microbiol Immunol Infect. 2024 Feb;57(1):1-10. doi: 10.1016/j.jmii.2023.12.006. Epub 2023 Dec 28. J Microbiol Immunol Infect. 2024. PMID: 38177001
-
Mpox Clinical Presentation, Diagnostic Approaches, and Treatment Strategies: A Review.JAMA. 2024 Nov 19;332(19):1652-1662. doi: 10.1001/jama.2024.21091. JAMA. 2024. PMID: 39401235 Review.
-
Multi-epitope vaccines: charting a new frontier in monkeypox prevention and control.Hum Cell. 2025 Jul 9;38(5):126. doi: 10.1007/s13577-025-01255-2. Hum Cell. 2025. PMID: 40632349 Review.
Cited by
-
Decoding and Unravelling Mpox, Herpes, and Syphilis Infections: A State of Art Review.Curr Pharm Biotechnol. 2025;26(10):1532-1548. doi: 10.2174/0113892010293479240709074020. Curr Pharm Biotechnol. 2025. PMID: 39039685 Review.
-
Cross-reactive antibody response to Monkeypox virus surface proteins in a small proportion of individuals with and without Chinese smallpox vaccination history.BMC Biol. 2023 Oct 2;21(1):205. doi: 10.1186/s12915-023-01699-8. BMC Biol. 2023. PMID: 37784185 Free PMC article.
-
Recent Outbreak of Monkeypox: Implications for Public Health Recommendations and Crisis Management in India.Cureus. 2023 Sep 21;15(9):e45671. doi: 10.7759/cureus.45671. eCollection 2023 Sep. Cureus. 2023. PMID: 37868437 Free PMC article. Review.
-
The Emergence of Mpox: Epidemiology and Current Therapeutic Options.Curr Pharmacol Rep. 2023;9(3):144-153. doi: 10.1007/s40495-023-00318-y. Epub 2023 May 5. Curr Pharmacol Rep. 2023. PMID: 37213566 Free PMC article. Review.
-
Human Monkeypox Experience in a Tertiary Level Hospital in Milan, Italy, between May and October 2022: Epidemiological Features and Clinical Characteristics.Viruses. 2023 Mar 2;15(3):667. doi: 10.3390/v15030667. Viruses. 2023. PMID: 36992376 Free PMC article.
References
REFERENCES
-
- Oliveira GP, Rodrigues RAL, Lima MT, Drumond BP, Abrahão JS. Poxvirus host range genes and virus-host spectrum: a critical review. Viruses. 2017;9(11):331.
-
- Centers for Disease Control and Prevention (CDC). Update: multistate outbreak of monkeypox-Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin 2003. MMWR Morb Mortal Wkly Rep. 2003;52(24):561-564.
-
- Sah R, Mohanty A, Siddiq A, et al. Monkeypox reported in India-South East Asia region: health and economic challenges. Lancet Reg Health-Southeast Asia. 2022;4:100063.
-
- Sharma A, Priyanka, Fahrni ML, Choudhary OP. Monkeypox outbreak: new zoonotic alert after the COVID-19 pandemic (in eng). Int J Surg. 2022;104:106812.
-
- Ortiz-Martínez Y, Rodríguez-Morales AJ, Franco-Paredes C, et al. Monkeypox-a description of the clinical progression of skin lesions: a case report from Colorado, USA. Ther Adv Infect Dis. 2022;9:20499361221117726.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials